Manufacturing Execution Systems Market Analysis

Deployment Mode (On-premise, On-Cloud, Hybrid)

The hybrid segment in the manufacturing execution systems market is estimated to gain a robust revenue share of 43% in the coming years. The segment growth can be attributed to the growing oil & gas sector.  As the industry is expanding the demand for real-time data is also expected to rise in the sector since the industry often operates in challenging environments. For instance, long-term planning, connectivity solutions, and short-term operations schedules are supported by MES in the oil and gas industry.

End-Use (Automotive, Pharmaceutical, Food & Beverages, Aerospace & Defense)

Manufacturing execution systems market from the pharmaceutical segment is set to garner a notable share shortly. The growth of the segment is driven by the rising pharmaceutical sector. It is expected that owing to the rising pharmaceutical industry the demand for MES is also expected to rise since it gives the pharmaceutical industry considerable manufacturing cost reductions and improved regulatory compliance by providing tools for documentation. Also, it offers the functionality to link patient-related data with the production environment since MES solutions are only focused on the manufacture of medications inside the facility. Besides this, MES may enhance business procedures in the production supply chain, and enhance product quality. According to estimates, by 2030, it is anticipated that the Indian pharmaceutical industry's overall market will be worth over USD 125 billion.

Our in-depth analysis of the global sector includes the following segments: